Tissue-engineered matrices as functional delivery systems: Adsorption and release of bioactive proteins from degradable composite scaffolds

Journal of Biomedical Materials Research - Part A

Volumn 94, Issue 2, 2010, Pages 568-575

  Cushnie, Emily K ^a   Khan, Yusuf M ^b,c   Laurencin, Cato T ^b,c  

^a University of Virginia   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Bioengineering; Bone; Hydroxyapatite; Implants; Protein delivery

Indexed keywords

ADSORPTION; APATITE; BIOLOGICAL MATERIALS; BIOMATERIALS; BIOMECHANICS; BONE; GRAFTS; HYDROXYAPATITE; LOADING; MECHANICAL PROPERTIES; PROTEINS; TISSUE ENGINEERING;

AQUEOUS BUFFER; BIOACTIVE PROTEINS; BIOLOGICAL COMPONENTS; BONE GRAFT; CELL INTERACTION; CYTOCHROME C; DEGRADABLE COMPOSITES; DELIVERY SYSTEMS; FUNCTIONALIZED; GROWTH FACTOR; HYDROXYAPATITE IMPLANTS; LOADING EXPERIMENT; MATRIX; MODEL PROTEINS; OSTEOCONDUCTIVE; PHOSPHATE-BUFFERED SALINE SOLUTIONS; PHYSICAL ENTRAPMENT; POLY LACTIDE-CO-GLYCOLIDE; POROUS HYDROXYAPATITE; POSSIBLE SOLUTIONS; PROTEIN ADSORPTION; PROTEIN DELIVERY; PROTEIN LOADINGS; PROTEIN RETENTION; PROTEIN RETENTION TIME; SCAFFOLD PROTEIN; TISSUE ENGINEERING APPLICATIONS;

SCAFFOLDS;

BIOMATERIAL; CYTOCHROME C; HYDROXYAPATITE; PHOSPHATE BUFFERED SALINE; SCAFFOLD PROTEIN; MICROSPHERE; POLYGLYCOLIC ACID; POLYMER; PROTEIN;

ADSORPTION; ARTICLE; BIODEGRADABLE IMPLANT; BONE GRAFT; CELL INTERACTION; DIFFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TISSUE ENGINEERING; CHEMISTRY; DRUG DELIVERY SYSTEM; EVALUATION STUDY; HUMAN; MATERIALS TESTING; METABOLISM; POROSITY; PROCEDURES; TISSUE SCAFFOLD;

ADSORPTION; BIOCOMPATIBLE MATERIALS; CYTOCHROMES C; DIFFUSION; DRUG DELIVERY SYSTEMS; DURAPATITE; HUMANS; MATERIALS TESTING; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS; POROSITY; PROTEINS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77953815613     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32722     Document Type: Article

References (18)

1. Khan YM, Katti DS, Laurencin CT. Novel polymer-synthesized ceramic composite-based system for bone repair: An in vitro evaluation. J Biomed Mater Res A 2004;69:728-737.
2. Khan YM, Cushnie EK, Laurencin CT. In situ synthesized ceramicpolymer composites for bone tissue engineering: Bioactivity and degradation studies. J Mater Sci 2007;42:4183-4190.
3. Cushnie EK, Khan YM, Laurencin CT. Amorphous hydroxyapatitesintered polymeric scaffolds for bone tissue regeneration: Physical characterization studies. J Biomed Mater Res A 2008;84:54-62.
4. Matsuno T, Uchimura E, Ohno T, Satoh T, Sogo Y, Ito A, Yamazaki A, Ishikawa Y, Kondo N, Ichinose N. Hydroxyapatite containing immobilized collagen and fibronectin promotes bone regeneration. Int Congr Ser 2005;1284:330-331.
5. Hanks T, Atkinson BL. Comparison of cell viability on anorganic bone matrix with or without P-15 cell binding peptide. Biomaterials 2004;25:4831-4836.
6. Muller P, Bulnheim U, Diener A, Luthen F, Teller M, Klinkenberg ED, Neumann HG, Nebe B, Liebold A, Steinhoff G, Rychly J. Calcium phosphate surfaces promote osteogenic differentiation of mesenchymal stem cells. J Cell Mol Med 2008;12:281-291.
7. Duggirala SS, Mehta RC, DeLuca PP. Interaction of recombinant human bone morphogenetic protein-2 with poly(D,L lactide-coglycolide) microspheres. Pharm Dev Technol 1996;1:11-19.
8. Schrier JA, DeLuca PP. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery. Pharm Dev Technol 1999;4:611-621.
9. Woo BH, Fink BF, Page R, Schrier JA, Jo YW, DeLuca M, Vasconez HC, DeLuca PP. Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Pharm Res 2001;18:1747-1753.
10. Dong X, Wang Q, Wu T, Pan HU. Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface. Biophys J 2007;93:750-759.
11. Sigma. Sigma Cytochrome c Data Sheet, Product Number C7752. Sigma, Saint Louis: MO; 2008.
12. Tabata Y. Tissue regeneration based on growth factor release. Tissue Eng 2003;9:S5-S15. (Pubitemid 37046603)
13. Wernike E, Hofstetter W, Liu Y, Hunziker EB, Siebenrock KA, Klenke FM. Long-term release of bioactive BMP-2 from CaP ceramics via cell mediated material resorption. Eur Cell Mater 2007;14-S1:25.
14. Sharifi R, Ratanawong C, Jung A, Wu Z, Browneller R, Lee M. Therapeutic effects of leuproelin microspheres in prostate cancer. Adv Drug Delivery Rev 1997;28:121-138.
15. Okada H, Yamamoto M, Heya T, Inoue Y, Kamei S, Ogawa Y, Toguchi H. Drug delivery using biodegradable microspheres. J Controlled Release 1994;28:121-129.
16. Khan YM. Development of a polymer/ceramic composite scaffold for bone tissue engineering, Doctorial Thesis, Drexel University, 2005.
17. Treybal RE. Mass Transfer Operations, 2nd ed. New York, NY: McGraw-Hill Book; 1968.
18. Geankoplis CJ.Transport Process and Unit Operations, 3rd ed. Upper Saddle River, NJ: Prentice Hall; 1993.